Triple therapy aims to cure High-Risk skin cancer without disfigurement
⭐️ CURE ⭐️
Recruiting now
This study tests whether combining an immunotherapy drug (cemiplimab), a topical cream (imiquimod), and laser therapy before surgery can cure high-risk basal cell skin cancer. About 18 adults with large or difficult-to-treat tumors will receive the combination or immunotherapy al…
Phase: PHASE1, PHASE2 • Sponsor: Instituto Oncológico Dr Rosell • Aim: ⭐️ CURE ⭐️
Last updated Jun 17, 2026 12:05 UTC